You have activated the high contrast version of the site. For more info on this topic, please visit this page.
In collaboration with the World Health Organization, the University Hospitals of Geneva (HUG) are conducting a phase 1 trial to test the safety of the Ebola vaccine VSV-ZEBOV and its ability to trigger an immune response in healthy adult volunteers.
Emerging viruses: these words evoke elusive enemies and uncontrollable health crises. An unknown disease hits a corner of the world and has repercussions on global health. Like H5N1or MERS several years ago, Ebola in 2015 and Zika in 2016.